Skip to main content
Clinical Trials/NCT01654913
NCT01654913
Completed
Not Applicable

Influence of the Inspired Oxygen Fraction on the Noninvasive Measurement of Hemoglobin Using Two Different Devices (Namely Pronto 7 and NBM-200)

Hopital Foch2 sites in 1 country47 target enrollmentJuly 2012
ConditionsAnesthesia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anesthesia
Sponsor
Hopital Foch
Enrollment
47
Locations
2
Primary Endpoint
influence of the inspired oxygen fraction on the noninvasive measurement of hemoglobin (Pronto 7 and NBM-200 devices)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study examines the effect of oxygen supplementation on the non-invasive measurement of hemoglobin.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
November 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • adult patients scheduled for a potentially hemorrhagic surgical procedure

Exclusion Criteria

  • anomaly (malformation, infection, swelling, irritation, ulceration, degenerative changes or significant edema) of the fingers,

Outcomes

Primary Outcomes

influence of the inspired oxygen fraction on the noninvasive measurement of hemoglobin (Pronto 7 and NBM-200 devices)

Time Frame: one year (end of the recrutement period)

Statistical comparison of the 3 measurements (baseline, FiO2 50%, FiO295%) for each device

Secondary Outcomes

  • agreement between the noninvasive methods of measurement of hemoglobin and the laboratory analysis(one year (end of the recrutement period))

Study Sites (2)

Loading locations...

Similar Trials